Inactive Instrument

AVITA Medical, Inc. Share Price Other OTC

Equities

AVHHL

AU000000AVH4

Biotechnology & Medical Research

Financials

Sales 2024 * 11Cr 7.47Cr 623.54Cr Sales 2025 * 16Cr 10Cr 867.28Cr Capitalization 36Cr 24Cr 1.98TCr
Net income 2024 * -6.6Cr -4.35Cr -363.11Cr Net income 2025 * -3.2Cr -2.11Cr -176.05Cr EV / Sales 2024 * 2.86 x
Net cash position 2024 * 3.62Cr 2.38Cr 198.93Cr Net Debt 2025 * 22.68L 14.94L 12Cr EV / Sales 2025 * 2.3 x
P/E ratio 2024 *
-5.29 x
P/E ratio 2025 *
-11.9 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.29%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on AVITA Medical, Inc.

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
Related indices
More about the company